ATE326220T1 - Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalieren - Google Patents

Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalieren

Info

Publication number
ATE326220T1
ATE326220T1 AT01125055T AT01125055T ATE326220T1 AT E326220 T1 ATE326220 T1 AT E326220T1 AT 01125055 T AT01125055 T AT 01125055T AT 01125055 T AT01125055 T AT 01125055T AT E326220 T1 ATE326220 T1 AT E326220T1
Authority
AT
Austria
Prior art keywords
same
compound
adenosylmethionine
inhalation
administration
Prior art date
Application number
AT01125055T
Other languages
English (en)
Inventor
Ivo Pera
Original Assignee
Ivo Pera
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivo Pera filed Critical Ivo Pera
Application granted granted Critical
Publication of ATE326220T1 publication Critical patent/ATE326220T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AT01125055T 2001-03-05 2001-10-22 Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalieren ATE326220T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001PI000015A ITPI20010015A1 (it) 2001-03-05 2001-03-05 Metodo per la somministrazione di s-adenosil-metionina,sottoforma di micropolvere secca,tramite inalazione

Publications (1)

Publication Number Publication Date
ATE326220T1 true ATE326220T1 (de) 2006-06-15

Family

ID=11452986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01125055T ATE326220T1 (de) 2001-03-05 2001-10-22 Verabreichungsverfahren von s-adenosylmethionin in form eines mikrofeinen pulvers durch inhalieren

Country Status (4)

Country Link
EP (1) EP1238665B1 (de)
AT (1) ATE326220T1 (de)
DE (1) DE60119687D1 (de)
IT (1) ITPI20010015A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130426A1 (it) * 2013-03-20 2014-09-21 Gnosis Spa S-adenosilmetionina sterile ad alto contenuto di isomero attivo per soluzioni iniettabili e procedimento per ottenerla
GB2525626A (en) * 2014-04-29 2015-11-04 Alexander Francois Robert Templet Composition and method for inhalable nutritional element

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT8219012A0 (it) * 1982-01-06 1982-01-06 Ausonia Farma Srl Metodo per la somministrazione orale di sostanze sotto forma di liposomi, e relative formulazioni farmaceutiche.
JPS59175433A (ja) * 1983-03-24 1984-10-04 Kanegafuchi Chem Ind Co Ltd Ｓ−アデノシル−ｌ−メチオニン含有組成物
US5669378A (en) 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
US5944012A (en) 1996-03-25 1999-08-31 Pera; Ivo E. Method for dispensing antioxidant vitamins by inhalation background of the invention
DE19631085A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut

Also Published As

Publication number Publication date
EP1238665B1 (de) 2006-05-17
ITPI20010015A1 (it) 2002-09-05
DE60119687D1 (de) 2006-06-22
EP1238665A1 (de) 2002-09-11

Similar Documents

Publication Publication Date Title
US6138673A (en) Inhalation device and method
TR200002692T2 (tr) Aerosol haline getirilen aktif maddenin verilmesi.
EA200100338A1 (ru) Способ и устройство для введения действующего вещества в виде аэрозоли в легкие пациента
CA2425489A1 (en) Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis
EP1829533A3 (de) Pharmazeutische Formulierungen für Pulverinhalatoren
WO2000030607A8 (en) PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a
BR0012013A (pt) Métodos de aerossolizar uma formulação farmacêutica, e de administrar uma formulação farmacêutica, dispositivo de aerossolização, sistema de aerossolização, e, receptáculo
CA2411047A1 (en) Stable pharmaceutical solution formulations for pressurised metered dose inhalers
AU2001252306A1 (en) Powder inhaler
DE60119687D1 (de) Verabreichungsverfahren von S-Adenosylmethionin in Form eines mikrofeinen Pulvers durch Inhalieren
Crompton et al. Session Chairmen's Summary
FI77784C (fi) Inhaleringsanordning.
TH59260A3 (th) การให้สารออกฤทธิ์ที่ได้รับการทำเป็นแอโรซอล
Bauer et al. Special Applications of Aerosol Therapy
MXPA98000223A (en) Device and method of inhalac

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties